Enoxaparin sodium 40mg/0.4ml solution for injection pre-filled syringes
NHS hospitals in England used £55,609,722 of indicative cost of Enoxaparin sodium 40mg/0.4ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 1.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Enoxaparin sodium 40mg/0.4ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Enoxaparin sodium 40mg/0.4ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £2,171,689 |
| Barts Health Nhs Trust | £1,709,745 |
| Western Sussex Hospitals Nhs Found Trust | £1,542,709 |
| Leeds Teaching Hpls Nhs Trust | £1,485,598 |
| Nottingham University Hospitals Trust | £1,465,385 |
| Southend Univ Hosp Nhs Foundation Trust | £1,295,910 |
| Aintree University Hospital Nhs Ft | £1,132,487 |
| University Hpls Of Leicester Nhs Trust | £1,113,708 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,078,907 |
| Derby Teaching Hospitals Nhs Found Trust | £1,046,684 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.